跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
18F-1
首页
药物
18F-1
18F-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT
EP 3060205 A4
申请人: MASSACHUSETTS GEN HOSPITAL
优先权: 2013
CN
EP
US
WO
10 件公开
CN 105061376 A
申请人: GEN HOSPITAL CORP
优先权: 2009
CN
US
3 件公开
US 2014140927 A1
申请人: ELMALEH DAVID R
优先权: 2013
US
2 件公开
Imaging agents
US 7837982 B2
申请人: UNIV EMORY
优先权: 2006
US
5 件公开
COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC STROKE
EP 3380095 B1
申请人: MASSACHUSETTS GEN HOSPITAL
优先权: 2015
CN
EP
US
4 件公开
Radicicol Derivatives Useful for Position Emission Tomography
US 2008311038 A1
申请人: AUBERSON YVES
优先权: 2005
EP
US
WO
3 件公开
N-CYCLOPROPYL-1-(4-(4-(FLUORO-18F)PHENYL)PYRIMIDIN-5-YL)-N-METHYLPIPERIDINE-4-CARBOXAMIDE AND USES IN PET IMAGING
EP 4568679 A4
申请人: UNIV EMORY
优先权: 2022
EP
US
WO
3 件公开
CYCLEN BASED COMPOUNDS AND THEIR GD(III) COMPLEXES FOR USE AS MULTIMODAL PET/MRI CONTRAST AGENTS
EP 4619048 A1
申请人: USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I
优先权: 2022
CN
EP
WO
3 件公开
MODULATORS OF NEURODEGENERATION
EP 4747230 A2
申请人: MASSACHUSETTS GEN HOSPITAL
优先权: 2023
CN
EP
WO
3 件公开
Pharmaceutical formulations
US 12036290 B2
申请人: BLUE EARTH DIAGNOSTICS LTD
优先权: 2020
CN
US
3 件公开
18F FLUORO-BENZOYL LABELLED BIOLOGICAL ACTIVE COMPOUNDS AS DIAGNOSTIC IMAGING AGENTS AS WELL AS BENZOTRIAZOL-1-YLOXY-BENZOYL , 2,5-DIOXO-PYRROLIDIN-1-YLOXY)BENZOYL AND TRIMETHYLAMMONIO-BENZOYL PRECURSERS THEREOF
EP 2146753 A2
申请人: BAYER SCHERING PHARMA AG
优先权: 2007
EP
WO
2 件公开
LABELING COMPOUND FOR PET
US 2012230914 A1
申请人: WATANABE YASUYOSHI
优先权: 2009
US
WO
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈